Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease
Abstract In this exploratory study from a randomized double‐blinded crossover trial including 70 patients with coronary heart disease and self‐perceived muscular side effects of statins, we aimed to determine the relationship between low‐density lipoprotein cholesterol (LDL‐C) reduction and atorvast...
Saved in:
Main Authors: | E. Sverre (Author), J. Munkhaugen (Author), O. Kristiansen (Author), H. Weedon‐Fekjær (Author), K. Peersen (Author), E. Gjertsen (Author), L. Gullestad (Author), S. Bergan (Author), E. Husebye (Author), N. T. Vethe (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mevalonate in blood and muscle: Response to atorvastatin treatment and the relationship to statin intolerance in patients with coronary heart disease
by: Trine Lauritzen, et al.
Published: (2024) -
Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
by: Bülent Nuri Kalaycı
Published: (2023) -
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
by: Niki Katsiki, et al.
Published: (2023) -
Comparative study of the effect of atorvastatin and fenofibrate on high-density lipoprotein cholesterol levels in patients with type 2 diabetes
by: Mostafa Najafipour, et al.
Published: (2018) -
The N‐Acetylgalactosamine‐conjugated small interfering RNA inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions
by: Dario Lehoux, et al.
Published: (2023)